About Us

CytoKIND Diagnostics strives to improve the lifespan and health span of affected individuals by accelerating the differential diagnosis of Cytokine Release Syndrome in CAR-T Cell therapy patients through a simple and reliable mechanism.

The vision of CytoKIND Diagnostics is to provide valuable diagnostic results for patients undergo cancer therapies. CytoKIND Diagnostics utilizes its proprietary technology to reduce ICU stays and helps patients get back to doing the activities they love.

Innovation - Providing technological advances to improve patient treatment

Integrity - Providing highly accurate results, ensuring patient safety

Quality - We seek to provide the highest quality products for quality patient care

Collaboration - We value the input from our stakeholders and most importantly: the patients